Investigational drug MLN0128, a novel TORC1/2 inhibitor,...

Breast Cancer Research and Treatment 2012 / 12 Vol. 136; Iss. 3

Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models

Yesim Gökmen-Polar, Yi Liu, Rachel A. Toroni, Kerry L. Sanders, Rutika Mehta, Sunil Badve, Christian Rommel, George W. Sledge Jr.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
136
Language:
english
DOI:
10.1007/s10549-012-2298-8
Date:
December, 2012
File:
PDF, 525 KB
english, 2012
Conversion to is in progress
Conversion to is failed